Arman Soleymani, MD | |
9200 Calumet Ave, Suite 203, Munster, IN 46321-2885 | |
(219) 228-4200 | |
(844) 965-9457 |
Full Name | Arman Soleymani |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 23 Years |
Location | 9200 Calumet Ave, Munster, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740203819 | NPI | - | NPPES |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dermio Dermatology Llc | 7315206687 | 17 |
News Archive
Cyanide poisoning is often fatal and typically affects victims of industrial accidents, terrorist attacks, or structural fires. Based on research conducted at the Center for Drug Design at the University of Minnesota, startup Vytacera Pharma Inc. will develop and market Sulfanegen, a treatment for cyanide poisoning. Sulfanegen could be administered by first responders in the case of a mass casualty emergency, or to victims of smoke inhalation from a house fire.
An international team of scientists has announced a new advance in the fight against Alzheimer's disease by identifying a new drug target for not only improving symptoms of brain degeneration – but also to extend the life-span of the terminally ill mice.
A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) has demonstrated a novel and accurate test for early diagnosis of Turner syndrome. Turner syndrome affects one in 1,500 to 2,000 female live births and early diagnosis allows for the timely management of short stature and co-morbid conditions including cardiac and renal problems.
Schizophrenia, which can cause disrupted thought and mood, delusions and hallucinations, is among the most debilitating mental disorders and the most mysterious.
› Verified 3 days ago
Entity Name | Dermio Dermatology Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1811402423 PECOS PAC ID: 7315206687 Enrollment ID: O20180111002019 |
News Archive
Cyanide poisoning is often fatal and typically affects victims of industrial accidents, terrorist attacks, or structural fires. Based on research conducted at the Center for Drug Design at the University of Minnesota, startup Vytacera Pharma Inc. will develop and market Sulfanegen, a treatment for cyanide poisoning. Sulfanegen could be administered by first responders in the case of a mass casualty emergency, or to victims of smoke inhalation from a house fire.
An international team of scientists has announced a new advance in the fight against Alzheimer's disease by identifying a new drug target for not only improving symptoms of brain degeneration – but also to extend the life-span of the terminally ill mice.
A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) has demonstrated a novel and accurate test for early diagnosis of Turner syndrome. Turner syndrome affects one in 1,500 to 2,000 female live births and early diagnosis allows for the timely management of short stature and co-morbid conditions including cardiac and renal problems.
Schizophrenia, which can cause disrupted thought and mood, delusions and hallucinations, is among the most debilitating mental disorders and the most mysterious.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Arman Soleymani, MD 9200 Calumet Ave, Suite 203, Munster, IN 46321-2885 Ph: (219) 228-4200 | Arman Soleymani, MD 9200 Calumet Ave, Suite 203, Munster, IN 46321-2885 Ph: (219) 228-4200 |
News Archive
Cyanide poisoning is often fatal and typically affects victims of industrial accidents, terrorist attacks, or structural fires. Based on research conducted at the Center for Drug Design at the University of Minnesota, startup Vytacera Pharma Inc. will develop and market Sulfanegen, a treatment for cyanide poisoning. Sulfanegen could be administered by first responders in the case of a mass casualty emergency, or to victims of smoke inhalation from a house fire.
An international team of scientists has announced a new advance in the fight against Alzheimer's disease by identifying a new drug target for not only improving symptoms of brain degeneration – but also to extend the life-span of the terminally ill mice.
A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) has demonstrated a novel and accurate test for early diagnosis of Turner syndrome. Turner syndrome affects one in 1,500 to 2,000 female live births and early diagnosis allows for the timely management of short stature and co-morbid conditions including cardiac and renal problems.
Schizophrenia, which can cause disrupted thought and mood, delusions and hallucinations, is among the most debilitating mental disorders and the most mysterious.
› Verified 3 days ago
Dr. Adam P Whittington, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 800 Macarthur Blvd Ste 6, Munster, IN 46321 Phone: 219-703-2417 Fax: 219-703-6947 | |
Dr. Vivek Singam, MD Dermatology Medicare: Medicare Enrolled Practice Location: 9200 Calumet Ave # 203, Munster, IN 46321 Phone: 219-228-4200 | |
Dr. Lauren Elisabeth Cerullo, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9200 Calumet Ave, Ste 203, Munster, IN 46321 Phone: 219-228-4200 Fax: 844-965-9457 | |
Mathew Joseph, Dermatology Medicare: Medicare Enrolled Practice Location: 9200 Calumet Ave # 203, Munster, IN 46321 Phone: 219-228-4200 | |
Ahmad Fathi, MD Dermatology Medicare: Medicare Enrolled Practice Location: 9130 Columbia Ave, Suite A, Munster, IN 46321 Phone: 219-836-4343 Fax: 219-836-4387 | |
Dr. Mark Gordon, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 7905 Calumet Ave, Munster, IN 46321 Phone: 219-836-7214 Fax: 219-836-7299 | |
Dr. Namrata Jagdish Shah, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 1950 45th St Ste 200, Munster, IN 46321 Phone: 219-912-3376 Fax: 219-529-6267 |